5-Amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione, 97.0%, 5g

GC capillary column ROTI®Cap-1701, 60 m, 0.25 mm, 0.50 µm, 1 Piece(s)

2-Bromo-6-fluoro-3-methylpyridine, 95.0%, 100mg

Tetrahydro-2H-thiopyran-4-amine, 95.0%, 5g

Anti-Gb3 Monoclonal Antibody1vial

6-Methyl-5-nitropyridin-2-ol, 97.0%, 1g

O-(4-Nitrobenzyl)hydroxylamine hydrochloride, 95.0%, 1g

(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, 98%, 10mg

TERT-BUTYL 4-((3-BROMO-2-OXOPYRIDIN-1(2H)-YL)METHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

N-(4-Bromophenyl)succinimide, 97%, 25g

BENZYL (S)-(1-OXO-1-((2-OXO-2-PHENYLETHYL)AMINO)PROPAN-2-YL)CARBAMATE, 95%, 100mg

(3,4-Dimethoxy-phenyl)-acetic acid, 97.0%, 500g

methyl 6-oxohexahydropyridazine-4-carboxylate, 250mg